Episode

How Jew hatred is the gateway drug for defending dictatorships

Podcast
Hub Podcasts
Published
May 29, 2026
Duration seconds
958
Processing state
not_requested
Canonical source
https://shows.acast.com/hub-podcasts/episodes/how-jew-hatred-is-the-gateway-drug-for-defending-dictatorshi
Audio
https://sphinx.acast.com/p/open/s/69cc1a3992d007a7658eee4e/e/6a19134579185d64dfceda98/media.mp3
JSON
/v1/public/podcasts/hub-podcasts-4932773/episodes/how-jew-hatred-is-the-gateway-drug-for-defending-dictatorships
Markdown
/podcast/hub-podcasts-4932773/how-jew-hatred-is-the-gateway-drug-for-defending-dictatorships.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hub-podcasts-4932773/episodes/how-jew-hatred-is-the-gateway-drug-for-defending-dictatorships/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hub-podcasts-4932773/how-jew-hatred-is-the-gateway-drug-for-defending-dictatorships.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Hub Headlines features audio versions of the best commentaries and analysis published daily in The Hub . Enjoy listening to original and provocative takes on the issues that matter while you are on the go. 0:19 - The antisemitism ‘Trojan Horse’: How Jew hatred is the gateway drug for defending dictatorships , by Harrison Lowman 10:39 - What the Pope’s AI takedown and defence of humanity can teach us , by Renze Nauta This program is narrated by automated voices. To get full-length editions of popular Hub podcasts and other great perks, subscribe to the Hub for only $2 a week: https://thehub.ca/join/hero/ Subscribe to The Hub's podcast feed to get all our best content: https://tinyurl.com/3a7zpd7e (Apple) https://tinyurl.com/y8akmfn7 (Spotify)x Watch The Hub on YouTube: https://www.youtube.com/@TheHubCanada The Hub on X: https://x.com/thehubcanada?lang=en CREDITS: Alisha Rao – Producer & Editor Hosted on Acast. See acast.com/privacy for more information.